Classification
- Anatomical main groupAAlimentary tract and metabolism
- Therapeutic subgroupA16
- Pharmacological subgroupA16A
- Chemical subgroupA16AXVarious alimentary tract and metabolism products
- Chemical substanceA16AX11
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Brazil
Anvisa · 30 registrations
- BenexpecCosmed Industria de Cosmeticos e Medicamentos S.A.
- cloridrato de oxomemazina + iodeto de potássio + benzoato de sódio + guaifenesinaBrainfarma Indústria Química e Farmacêutica S.A
- cloridrato de oxomemazina + iodeto de potássio + benzoato de sódio + guaifenesinaLegrand Pharma Indústria Farmacêutica Ltda
- cloridrato de oxomemazina + iodeto de potássio + benzoato de sódio + guaifenesinaEms S/A
United States
FDA · 8 registrations
At a glance
- ATC code
- A16AX11
- ATC group
- Alimentary tract and metabolism
- Registers
- 6
- Historical lists
- 1
- Registrations
- 47
- With their own page
- 21
- Companies
- 31
All medicines with Benzoate
Human medicines from every register that match Benzoate by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
192 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Sodium Phenylacetate and Sodium BenzoateCombination | United States | 10%; 10% (2GM/20ML, 10%; 10% (5GM/50ML | solution | Marketed | Maia Pharms INC |
| AmmonulCombination | United States | 10%; 10% (5GM/50ML | solution | Not marketed | Bausch |
| Benzyl Benzoate | United States | 50% | emulsion | Not marketed | Lannett |
| UcephanCombination | United States | 100MG/ML; 100MG/ML | solution | Not marketed | B Braun |
| Rizatriptan Benzoate | United States | 10MG BASE, 5MG BASE | tablet, orally disintegrating | Marketed | Macleods Pharms LTD |
| Rizatriptan Benzoate | United States | 10MG BASE, 5MG BASE | tablet | Marketed | Natco Pharma LTD |
| Sodium Phenylacetate and Sodium Benzoate InjectionCombination | Saudi Arabia | Authorised | University of Iowa Pharmaceuticals | ||
| Amzoate | New Zealand | Soln 100 mg per ml | Funded | ||
| BenexpecCombination | Brazil | Authorised | Cosmed Industria de Cosmeticos e Medicamentos S.A. | ||
| Amlodipine Benzoate | United States | 1MG BASE/ML | suspension | Not marketed | Amneal |
| cloridrato de oxomemazina + iodeto de potássio + benzoato de sódio + guaifenesinaCombination | Brazil | Authorised | Ems S/A | ||
| cloridrato de oxomemazina + iodeto de potássio + benzoato de sódio + guaifenesinaCombination | Brazil | Authorised | Legrand Pharma Indústria Farmacêutica Ltda | ||
| cloridrato de oxomemazina + iodeto de potássio + benzoato de sódio + guaifenesinaCombination | Brazil | Authorised | Brainfarma Indústria Química e Farmacêutica S.A | ||
| Eaca BalsâmicoCombination | Brazil | Authorised | Zydus Nikkho Farmacêutica Ltda | ||
| BENZYL BENZOATE APPLICATION BP 25% w/v | Singapore | 25% w/v | emulsion | Authorised | Icm Pharma Pte. LTD. |
| AmmivoCombination | Canada | 100 MG / ML + 100 MG / ML | Solution | Authorised | Sterimax INC |
| ExpecCombination | Brazil | Authorised | Legrand Pharma Indústria Farmacêutica Ltda | ||
| MultitosseCombination | Brazil | Authorised | Ems S/A | ||
| SecreliseCombination | Brazil | Authorised | Ems S/A | ||
| TossexpecCombination | Brazil | Authorised | Brainfarma Indústria Química e Farmacêutica S.A | ||
| Benzonatate | United States | 100MG, 150MG, 200MG | capsule | Marketed | Ascent Pharms INC |
| KazanoCombination | United States | 12.5MG BASE; 1GM, 12.5MG BASE; 500MG | tablet | Marketed | Takeda Pharms USA |
| Maxalt | United States | 10MG BASE, 5MG BASE | tablet | Marketed | Organon LLC |
| Maxalt-MLT | United States | 10MG BASE, 5MG BASE | tablet, orally disintegrating | Marketed | Organon |
| Nesina | United States | 12.5MG BASE, 25MG BASE, 6.25MG BASE | tablet | Marketed | Takeda Pharms USA |